Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.430
-0.010 (-0.69%)
At close: Dec 5, 2025, 4:00 PM EST
1.420
-0.010 (-0.70%)
After-hours: Dec 5, 2025, 6:22 PM EST
Allogene Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -212.02 | -257.59 | -327.27 | -340.41 | -182.05 | -316.38 | |
| Depreciation & Amortization | 12.54 | 13.64 | 14.2 | 14.3 | 10.45 | 7.44 | |
| Asset Writedown & Restructuring Costs | 2.38 | 15.72 | 13.25 | - | - | 0.15 | |
| Loss (Gain) From Sale of Investments | -3.09 | -6.39 | 0.19 | 2.89 | 6.96 | 3.25 | |
| Loss (Gain) on Equity Investments | - | 1.69 | 10.67 | 12.88 | 4.09 | 67.31 | |
| Stock-Based Compensation | 42.39 | 51.74 | 65.95 | 83.6 | 80.82 | 65.26 | |
| Other Operating Activities | 4.87 | 5.69 | 6.58 | 2.33 | -73.13 | 3.96 | |
| Change in Accounts Payable | -1.8 | -0.5 | -7.5 | 4.87 | -0.77 | 0.62 | |
| Change in Unearned Revenue | - | - | - | -0.02 | -38.3 | 38.35 | |
| Change in Other Net Operating Assets | -3.61 | -24.3 | -13.81 | -0.95 | 7.12 | 14.96 | |
| Operating Cash Flow | -158.35 | -200.3 | -237.73 | -220.52 | -184.81 | -115.09 | |
| Capital Expenditures | -0.64 | -0.69 | -1.52 | -5.19 | -21.45 | -65.96 | |
| Investment in Securities | 117.52 | 76.38 | 164.81 | 111.35 | 185.1 | -439.17 | |
| Investing Cash Flow | 116.88 | 75.69 | 163.29 | 106.16 | 163.66 | -505.12 | |
| Issuance of Common Stock | 21.13 | 114.4 | 95.7 | 2.95 | 11.96 | 633.59 | |
| Other Financing Activities | 6.91 | 2.28 | - | - | - | - | |
| Financing Cash Flow | 28.04 | 116.68 | 95.7 | 2.95 | 11.96 | 633.59 | |
| Net Cash Flow | -13.42 | -7.94 | 21.25 | -111.41 | -9.19 | 13.38 | |
| Free Cash Flow | -158.99 | -200.99 | -239.25 | -225.71 | -206.26 | -181.05 | |
| Free Cash Flow Margin | - | -913609.09% | -251841.05% | -144685.90% | -180.79% | - | |
| Free Cash Flow Per Share | -0.73 | -1.03 | -1.52 | -1.58 | -1.52 | -1.50 | |
| Levered Free Cash Flow | -83.92 | -99.13 | -134.26 | -111.74 | -85.97 | -97.89 | |
| Unlevered Free Cash Flow | -83.39 | -99.02 | -134.26 | -111.74 | -85.97 | -97.89 | |
| Change in Working Capital | -5.41 | -24.8 | -21.31 | 3.9 | -31.95 | 53.92 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.